Red cell lipid peroxidation and antioxidant system in haemodialysed patients: Influence of recombinant human erythropoietin (r-HuEPO) treatment
- 1 July 1998
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 30 (4) , 507-512
- https://doi.org/10.1007/bf02550233
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Red Cell Lipid Peroxidation and Antioxidant System in Chronic Renal Failure Patients Treated with Recombinant Human ErythropoietinNephron, 1992
- Whole blood superoxide anion generation and efficiency of some erythrocyte antioxidant systems during recombinant human erythropoietin therapy of uremic anemiaFree Radical Biology & Medicine, 1991
- Treatment of Renal Anemia with Recombinant Human ErythropoietinAmerican Journal of Nephrology, 1989
- Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patientsFree Radical Biology & Medicine, 1989
- Anemia and Chronic Renal Failure: The Possible Role of the Oxidative State of GlutathioneNephron, 1989
- Rheology in Whole Blood and in Red Blood Cells under Recombinant Human Erythropoietin TherapyPublished by S. Karger AG ,1988
- Glutathione peroxidase activity and reduced glutathione content in erythrocytes of patients with chronic renal failure.Scandinavian Journal of Haematology, 1985
- Anemia of end-stage renal disease (ESRD)Kidney International, 1985
- [39] Assay for blood plasma or serumPublished by Elsevier ,1984
- Abnormal Red Cell Metabolism Causing Hemolysis in UremiaAnnals of Internal Medicine, 1973